AI assistant
Jade Biosciences, Inc. — Director's Dealing 2026
Feb 13, 2026
33383_dirs_2026-02-13_abadeffb-2e1c-41c9-b0ec-963ccda565a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Jade Biosciences, Inc. (JBIO)
CIK: 0001798749
Period of Report: 2026-02-12
Reporting Person: Balta Elizabeth (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-12 | Common Stock | A | 28125 | — | Acquired | 28125 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-12 | Stock Option (Right to Buy) | $14.81 | A | 168750 | Acquired | 2036-02-11 | Common Stock (168750) | Direct |
Footnotes
F1: Represents restricted stock units ("RSUs"). 1/4 of the total number of RSUs granted shall vest on each of the first four anniversaries of February 15, 2026, the vesting commencement date, subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F2: This option represents a right to purchase shares of the Issuer's common stock, one quarter of which will vest on February 15, 2027, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.